343
Participants
Start Date
October 23, 2020
Primary Completion Date
November 10, 2021
Study Completion Date
November 19, 2021
Amlodipine
Amlodipine 1mg/ml Oral Solution; starting dose 1-2mg per day for patients not on amlodipine at entry; starting dose equivalent to current dose for patients on amlodipine at entry or at next 1-2mg dose step (according to clinical need based on the Investigator's judgement). Investigation of whether gradually increasing the dose of liquid amlodipine (can be an add-on to existing amlodipine tablets) in small increments (e.g. 1-2mg) will enable blood pressure control within the sequence 1mg, 2mg, 3mg, 4mg, 5mg, 6mg, 7mg, 8mg, 9mg to a maximum of 10mg amlodipine per day.
William Harvey Research Institute Clinical Research Centre, Queen Mary University of London, London
Queen Mary University London, London
Collaborators (2)
Closed Loop Medicine Ltd
UNKNOWN
Innovate UK
OTHER_GOV
Queen Mary University of London
OTHER